0000905718-17-000638.txt : 20170629 0000905718-17-000638.hdr.sgml : 20170629 20170629163021 ACCESSION NUMBER: 0000905718-17-000638 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20170629 DATE AS OF CHANGE: 20170629 EFFECTIVENESS DATE: 20170629 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NAM Biotech Fund II, LLC (Series IV) CENTRAL INDEX KEY: 0001708774 IRS NUMBER: 821725823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-289765 FILM NUMBER: 17938672 BUSINESS ADDRESS: STREET 1: 200 VESEY STREET STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10281-1023 BUSINESS PHONE: 212-417-8033 MAIL ADDRESS: STREET 1: 200 VESEY STREET STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10281-1023 D 1 primary_doc.xml X0707 D LIVE 0001708774 NAM Biotech Fund II, LLC (Series IV) 200 VESEY STREET 25TH FLOOR NEW YORK NY NEW YORK 10281-1023 212-417-8033 DELAWARE None None Limited Liability Company true 2017 - NAM Biotech Management LLC 200 Vesey Street 25th Floor New York NY NEW YORK 10281-1023 Executive Officer Manager - National Asset Management, Inc. 200 Vesey Street 25th Floor New York NY NEW YORK 10281-1023 Executive Officer Advisor David Levine c/o National Asset Management, Inc. 200 Vesey Street, 25th Floor New York NY NEW YORK 10281-1023 Executive Officer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.1 false true false true false 0 National Securities Corporation 7569 None None ONE UNION SQUARE, 600 UNIVERSITY STREET SUITE 2900 SEATTLE WA WASHINGTON 98101 All States false 40000000 0 40000000 false 0 4000000 true 0 true Assumes maximum commissions earned equal to 10% of gross proceeds. Excludes 5-year cash only placement agent warrants as set forth in the offering materials. 0 true false NAM Biotech Fund II, LLC (Series IV) /s/ David Levine David Levine Authorized Signatory 2017-06-29